The A-share innovative drug sector fluctuated and strengthened, with Tonghua Jinma hitting the daily limit, and Oulin Bio and Borui Pharmaceutical rising by more than 10%. Changshan Pharmaceutical, Qianyuan Pharmaceutical, Aoxing Pharmaceutical, Lianhuan Pharmaceutical and Zhendong Pharmaceutical followed suit.